What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Budget slips happen, but you can regain stability with a simple plan. Identify leaks, prioritize essentials, and set a realistic spending cap to regain confidence.
24,983 articlesA high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
The Metals Company stock faced a sharp pullback in early 2026 after a dramatic rally in the previous year. This artic...
A broad pullback in software stocks has created compelling opportunities for patient investors. Here are two names wi...
As Veracyte approaches its Q4 2025 earnings, investors want a clear view of revenue momentum, margins, and reimbursem...
Mercadolibre hits $14.5 billion in annual sales, marking a major milestone for Latin America's e-commerce and fintech...
Baidu shares slumped after a hefty impairment charge underscored the heavy costs of its AI push, even as AI Cloud rev...
Analysts kicked off the week with a wave of fresh calls on major names, signaling a mixed tone across consumer, tech ...
The latest CPI data gave a calm surface, but the big questions remain. Wednesday's report didn't solve the inflation ...
Oracle just posted best quarter in years, powered by cloud and AI demand. This article breaks down what changed, why ...
Carvana’s stock run looked extraordinary, up 4,300% in three years. But the strongest buy signal wasn’t the hype—it w...
The Baupost founder made a bold, selective move: trim a large Alphabet stake and pivot to a fintech name that slumped...
Kick off your week with a curated list of investing insights. These Monday reads translate market noise into actionab...